✦ LIBER ✦

Methotrexate, vinblastine, epidoxorubicin and cisplatin (M-VEC) in patients with locally advanced transitional bladder cancer

✍ Scribed by A. Frassoldati; M. Federico; F. Barbieri; M. Brausi; C. Pollastri; G. Berri; G. Castagnetti; P. P. Palladini; V. Silingardi

Book ID: 112963717
Publisher: Springer US
Year: 1991
Tongue: English
Weight: 421 KB
Volume: 8
Category: Article
ISSN: 1357-0560
DOI: 10.1007/bf02988861

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Initial Combination Chemotherapy with Ci

Initial Combination Chemotherapy with Cisplatin, Methotrexate and Vinblastine in Locally Advanced Transitional Cell Carcinoma—Response Rate and Pitfalls

✍ S. D. FOSSÅ; S. J. HARLAND; S. B. KAYE; D. RAGHAVAN; J. M. RUSSELL; M. K. B. PAR 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 604 KB

Adjuvant cisplatin plus methotrexate ver

Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin for locally advanced bladder cancer: Results of a randomised, multicenter phase III study in Germany

✍ J.L. Lehmann; M.R. Retz; S.W. Wellek; M.S. Stöckle; Participants Trial 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Carboplatin, methotrexate, and vinblasti

Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapy

✍ J. Bellmunt; J. Albanell; O. S. Gallego; A. Ribas; P. Vicente; J. Carulla; J. De 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

Background. A Phase I1 trial with a new regimen of methotrexate, carboplatin, and vinblastine (M-CAVI) was conducted for patients with bladder cancer who could not receive cisplatin-based chemotherapy. Methods. Treatment consisted of methotrexate (30 mg/m2) on days 1,15, and 22; carboplatin (300 mg

UP-03.49: Gemcitabine plus cisplatine ve

UP-03.49: Gemcitabine plus cisplatine versus methotrexate, vinblastine, doxorubicin and cisplatin in advanced or metastatic transitional cell carcinoma of bladder

✍ M. Arslan; B. Gunlusoy; T. Degirmenci; N. Nergiz; S. Minareci; A. Ayder 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Relative Efficacy of Perioperative Gemci

Relative Efficacy of Perioperative Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Adriamycin, and Cisplatin in the Management of Locally Advanced Urothelial Carcinoma of the Bladder

✍ Olga Yeshchina; Gina M. Badalato; Matthew S. Wosnitzer; Gregory Hruby; Arindam R 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 437 KB

Long-term follow-up in patients treated

Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: Cause for concern

✍ John P. Connor; Carl A. Olsson; Mitchell C. Benson; Ihor S. Sawczuk; Frederick R 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 340 KB